Intercure Ltd.

Regulatory Filings • May 20, 2021

see in the attached. false

��������� ��"�	2 380
INTERCURE LTD
Corporation no: 512051699	12810
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	20/05/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-028051	Time of broadcast: 14:08 14:08

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onsee in the attached.

InterCure_Trade_House_final_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 04/05/2021
Address: Medinat ha-Yehudim Street 85 , Herzliya 4676670   Israel , Tel: 077-4605012 , Fax: 09-7680244
E-mail address: office@canndoc-pharma.com   Company site: www.Intercure.co
Previous names of reporting entity:
Name of the Signatory: Blumenfeld Maayan Position of Signatory in the reporting corporation: Legal Counsel Name of Employer Company:
Address: Medinat ha-Yehudim Street 85 , Herzliya 4676670 Telephone: 077-4605012 Facsimile: 09-7680244 E-mail: maayanb@canndoc-pharma.com 1